M&A Advisory: OTC Brands
OTC Brands & Consumer Healthcare
PassionBio.tech are currently supporting a well-established European consumer healthcare platform in identifying new brand opportunities for integration into its existing operations. The platform focuses on the acquisition and development of proven OTC products with EBITDA between EUR 0.5 and 1 million, aiming to strengthen its footprint in key continental markets.
The company has successfully built category leadership across multiple segments through disciplined brand acquisition, focused investment, and operational scale. Its model is built on sustainable product development, omnichannel distribution, and strong local execution.
We are interested in connecting with founders, brand owners, and corporate licensors who are considering a strategic partner for long-term brand expansion in Europe.
Reach out at agile.advisor@passionbio.tech to explore a potential fit.